NDC properties for "bismuth subcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline hydrochloride 125 MG Oral Capsule" (RxCUI 1294619)

About this data

The tables show NDC propoerties for bismuth subcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline hydrochloride 125 MG Oral Capsule with the RxCUI 1294619

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product

Details for bismuth subcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline hydrochloride 125 MG Oral Capsule (RxCUI 1294619)

ANDA	ANDA205770
ANDA	ANDA217511
MMSL_CODE	BD19736
MMSL_CODE	CD19736
NDA	NDA050786
RxCUI	1294619
SNOMEDCT	1222703002
SPL_SET_ID	4c7f024d-ba26-43cf-a36f-597e2168cd9f
SPL_SET_ID	c07e32ee-cd99-405d-b5e2-927d9cb204ee
SPL_SET_ID	c4d66e80-f0bc-4e64-a0f0-630ef673da1b
VUID	4026131
Prescribable Synonym	bismuth subcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline HCl 125 MG Oral Capsule
RXNAV_STR	bismuth subcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline hydrochloride 125 MG Oral Capsule
RxNorm Name	bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG Oral Capsule
Tallman Synonym	bismuth subcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline hydrochloride 125 MG Oral Capsule
Related queries	Interactions (for RxCUI 1294619)

NDC Properties

NDC Item 49884015124

NDC 9	49884-151
NDC 10	49884-151-24
NDC Item	49884015124
ANDA	ANDA205770
COLORTEXT	white(white opaque)
Color	C48325 __
FDA SPL set id	700460
Imprint code	PAR;440
Labeler	Par Pharmaceutical, Inc.
Label type	HUMAN PRESCRIPTION DRUG
Marketing category	ANDA
Marketing effective time low	2023-03-07
Marketing status	ACTIVE
Score	1
Shape	C48336
Size	21 mm
Related queries	Properties for NDC 9 49884-151

NDC Item 49884015154

NDC 9	49884-151
NDC 10	49884-151-54
NDC Item	49884015154
Packaging	120 CAPSULE in 1 CARTON (49884-151-54)
ANDA	ANDA205770
COLORTEXT	white(white opaque)
Color	C48325 __
FDA SPL set id	700460
Imprint code	PAR;440
Labeler	Par Pharmaceutical, Inc.
Label type	HUMAN PRESCRIPTION DRUG
Marketing category	ANDA
Marketing effective time low	2023-03-07
Marketing status	ACTIVE
Score	1
Shape	C48336
Size	21 mm
Related queries	Properties for NDC 9 49884-151

NDC Item 50742028313

NDC 9	50742-283
NDC 10	50742-283-13
NDC Item	50742028313
Packaging	120 CAPSULE in 1 CARTON (50742-283-13)
ANDA	ANDA217511
COLORTEXT	white(opaque body and a white opaque cap)
Color	C48325 __
FDA SPL set id	821362
Imprint code	ING283
Labeler	Ingenus Pharmaceuticals, LLC
Label type	HUMAN PRESCRIPTION DRUG
Marketing category	ANDA
Marketing effective time low	2023-07-04
Marketing status	ACTIVE
Score	1
Shapetext	Hard Gelatin
Shape	C48336
Size	22 mm
Related queries	Properties for NDC 9 50742-283

NDC Item 61269038512

NDC 9	61269-385
NDC 10	61269-385-12
NDC Item	61269038512
Packaging	1 BLISTER PACK in 1 BOX (61269-385-12) / 120 CAPSULE in 1 BLISTER PACK
COLORTEXT	WHITE(opaque)
Color	C48325 __
FDA SPL set id	799824
Imprint code	Aptalis;BMT
Labeler	H2-Pharma, LLC
Label type	HUMAN PRESCRIPTION DRUG
Marketing category	NDA
Marketing effective time low	2023-07-31
Marketing status	ACTIVE
NDA	NDA050786
Score	1
Shape	C48336
Size	22 mm
Related queries	Properties for NDC 9 61269-385

NDC Item 49884015124

NDC 9	49884-151
NDC 10	49884-151-24
NDC Item	49884015124
ANDA	ANDA205770
COLORTEXT	white(white opaque)
Color	C48325 __
FDA SPL set id	700460
Imprint code	PAR;440
Labeler	Par Pharmaceutical, Inc.
Label type	HUMAN PRESCRIPTION DRUG
Marketing category	ANDA
Marketing effective time low	2023-03-07
Marketing status	ACTIVE
Score	1
Shape	C48336
Size	21 mm
Related queries	Properties for NDC 9 49884-151

NDC Item 49884015154

NDC 9	49884-151
NDC 10	49884-151-54
NDC Item	49884015154
Packaging	120 CAPSULE in 1 CARTON (49884-151-54)
ANDA	ANDA205770
COLORTEXT	white(white opaque)
Color	C48325 __
FDA SPL set id	700460
Imprint code	PAR;440
Labeler	Par Pharmaceutical, Inc.
Label type	HUMAN PRESCRIPTION DRUG
Marketing category	ANDA
Marketing effective time low	2023-03-07
Marketing status	ACTIVE
Score	1
Shape	C48336
Size	21 mm
Related queries	Properties for NDC 9 49884-151

NDC Item 50742028313

NDC 9	50742-283
NDC 10	50742-283-13
NDC Item	50742028313
Packaging	120 CAPSULE in 1 CARTON (50742-283-13)
ANDA	ANDA217511
COLORTEXT	white(opaque body and a white opaque cap)
Color	C48325 __
FDA SPL set id	821362
Imprint code	ING283
Labeler	Ingenus Pharmaceuticals, LLC
Label type	HUMAN PRESCRIPTION DRUG
Marketing category	ANDA
Marketing effective time low	2023-07-04
Marketing status	ACTIVE
Score	1
Shapetext	Hard Gelatin
Shape	C48336
Size	22 mm
Related queries	Properties for NDC 9 50742-283

NDC Item 61269038512

NDC 9	61269-385
NDC 10	61269-385-12
NDC Item	61269038512
Packaging	1 BLISTER PACK in 1 BOX (61269-385-12) / 120 CAPSULE in 1 BLISTER PACK
COLORTEXT	WHITE(opaque)
Color	C48325 __
FDA SPL set id	799824
Imprint code	Aptalis;BMT
Labeler	H2-Pharma, LLC
Label type	HUMAN PRESCRIPTION DRUG
Marketing category	NDA
Marketing effective time low	2023-07-31
Marketing status	ACTIVE
NDA	NDA050786
Score	1
Shape	C48336
Size	22 mm
Related queries	Properties for NDC 9 61269-385

NDC Item 49884015124

NDC 9	49884-151
NDC 10	49884-151-24
NDC Item	49884015124
ANDA	ANDA205770
COLORTEXT	white(white opaque)
Color	C48325 __
FDA SPL set id	700460
Imprint code	PAR;440
Labeler	Par Pharmaceutical, Inc.
Label type	HUMAN PRESCRIPTION DRUG
Marketing category	ANDA
Marketing effective time low	2023-03-07
Marketing status	ACTIVE
Score	1
Shape	C48336
Size	21 mm
Related queries	Properties for NDC 9 49884-151

NDC Item 49884015154

NDC 9	49884-151
NDC 10	49884-151-54
NDC Item	49884015154
Packaging	120 CAPSULE in 1 CARTON (49884-151-54)
ANDA	ANDA205770
COLORTEXT	white(white opaque)
Color	C48325 __
FDA SPL set id	700460
Imprint code	PAR;440
Labeler	Par Pharmaceutical, Inc.
Label type	HUMAN PRESCRIPTION DRUG
Marketing category	ANDA
Marketing effective time low	2023-03-07
Marketing status	ACTIVE
Score	1
Shape	C48336
Size	21 mm
Related queries	Properties for NDC 9 49884-151

NDC Item 50742028313

NDC 9	50742-283
NDC 10	50742-283-13
NDC Item	50742028313
Packaging	120 CAPSULE in 1 CARTON (50742-283-13)
ANDA	ANDA217511
COLORTEXT	white(opaque body and a white opaque cap)
Color	C48325 __
FDA SPL set id	821362
Imprint code	ING283
Labeler	Ingenus Pharmaceuticals, LLC
Label type	HUMAN PRESCRIPTION DRUG
Marketing category	ANDA
Marketing effective time low	2023-07-04
Marketing status	ACTIVE
Score	1
Shapetext	Hard Gelatin
Shape	C48336
Size	22 mm
Related queries	Properties for NDC 9 50742-283

NDC Item 61269038512

NDC 9	61269-385
NDC 10	61269-385-12
NDC Item	61269038512
Packaging	1 BLISTER PACK in 1 BOX (61269-385-12) / 120 CAPSULE in 1 BLISTER PACK
COLORTEXT	WHITE(opaque)
Color	C48325 __
FDA SPL set id	799824
Imprint code	Aptalis;BMT
Labeler	H2-Pharma, LLC
Label type	HUMAN PRESCRIPTION DRUG
Marketing category	NDA
Marketing effective time low	2023-07-31
Marketing status	ACTIVE
NDA	NDA050786
Score	1
Shape	C48336
Size	22 mm
Related queries	Properties for NDC 9 61269-385

NDC Item 49884015124

NDC 9	49884-151
NDC 10	49884-151-24
NDC Item	49884015124
ANDA	ANDA205770
COLORTEXT	white(white opaque)
Color	C48325 __
FDA SPL set id	700460
Imprint code	PAR;440
Labeler	Par Pharmaceutical, Inc.
Label type	HUMAN PRESCRIPTION DRUG
Marketing category	ANDA
Marketing effective time low	2023-03-07
Marketing status	ACTIVE
Score	1
Shape	C48336
Size	21 mm
Related queries	Properties for NDC 9 49884-151

NDC Item 49884015154

NDC 9	49884-151
NDC 10	49884-151-54
NDC Item	49884015154
Packaging	120 CAPSULE in 1 CARTON (49884-151-54)
ANDA	ANDA205770
COLORTEXT	white(white opaque)
Color	C48325 __
FDA SPL set id	700460
Imprint code	PAR;440
Labeler	Par Pharmaceutical, Inc.
Label type	HUMAN PRESCRIPTION DRUG
Marketing category	ANDA
Marketing effective time low	2023-03-07
Marketing status	ACTIVE
Score	1
Shape	C48336
Size	21 mm
Related queries	Properties for NDC 9 49884-151

NDC Item 50742028313

NDC 9	50742-283
NDC 10	50742-283-13
NDC Item	50742028313
Packaging	120 CAPSULE in 1 CARTON (50742-283-13)
ANDA	ANDA217511
COLORTEXT	white(opaque body and a white opaque cap)
Color	C48325 __
FDA SPL set id	821362
Imprint code	ING283
Labeler	Ingenus Pharmaceuticals, LLC
Label type	HUMAN PRESCRIPTION DRUG
Marketing category	ANDA
Marketing effective time low	2023-07-04
Marketing status	ACTIVE
Score	1
Shapetext	Hard Gelatin
Shape	C48336
Size	22 mm
Related queries	Properties for NDC 9 50742-283

NDC Item 61269038512

NDC 9	61269-385
NDC 10	61269-385-12
NDC Item	61269038512
Packaging	1 BLISTER PACK in 1 BOX (61269-385-12) / 120 CAPSULE in 1 BLISTER PACK
COLORTEXT	WHITE(opaque)
Color	C48325 __
FDA SPL set id	799824
Imprint code	Aptalis;BMT
Labeler	H2-Pharma, LLC
Label type	HUMAN PRESCRIPTION DRUG
Marketing category	NDA
Marketing effective time low	2023-07-31
Marketing status	ACTIVE
NDA	NDA050786
Score	1
Shape	C48336
Size	22 mm
Related queries	Properties for NDC 9 61269-385